Ondotyle Oral Spray contains Ondansetron 2mg, a selective 5-HT3 receptor antagonist widely used to prevent and treat nausea and vomiting. The oral spray formulation provides rapid absorption and convenient dosing, offering immediate relief to patients who have difficulty swallowing tablets.
Clinically, it is indicated for chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea, and post-operative nausea and vomiting (PONV). Ondansetron works by blocking serotonin receptors in the gastrointestinal tract and central nervous system, reducing the vomiting reflex effectively.
The spray formulation ensures precise dosing, quick onset of action, and ease of administration, particularly in pediatric, geriatric, and post-operative patients. It can be used in hospitals, oncology centers, and outpatient settings for optimal patient comfort.
Regular use under medical supervision helps in preventing dehydration, maintaining nutritional intake, and improving patient quality of life. Ondotyle Oral Spray is a trusted choice for antiemetic therapy, combining efficacy, safety, and patient convenience in a single formulation.